HCID 25210765, compound → HCID 59529905, compound
Reaction equation
[CH3:1][C:2]([OH:25])([CH3:24])[CH2:3][CH:4]1[CH2:9][CH2:8][N:7]([C:10]([C:12]2[NH:13][C:14]3[C:19]([CH:20]=2)=[CH:18][C:17]([N+:21]([O-])=O)=[CH:16][CH:15]=3)=[O:11])[CH2:6][CH2:5]1>CO.[C].[Pd]>[NH2:21][C:17]1[CH:18]=[C:19]2[C:14](=[CH:15][CH:16]=1)[NH:13][C:12]([C:10]([N:7]1[CH2:8][CH2:9][CH:4]([CH2:3][C:2]([CH3:24])([OH:25])[CH3:1])[CH2:5][CH2:6]1)=[O:11])=[CH:20]2Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 838 mg of 2-methyl-1-{1-[(5-nitro-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol in 15 mL of methanol was added 80 mg of 10% palladium-carbon, followed by stirring under a hydrogen atmosphere at room temperature for 1 day. Insoluble material was removed by filtration through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1], and then solidified from hexane-ethyl acetate to obtain 576 mg of 1-{1-[(5-amino-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-methylpropan-2-ol as a pale brown solid.
Workup
- customInsoluble material was removed by filtration through Celite
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1]
Sources & evidence
- ORD record
- ord-5aabf934f9804c5e95c25ba02b6fba31
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513422B2
Reaction notes
Loading…